Symbol="MIRM"
AssetType="Common Stock"
Name="Mirum Pharmaceuticals Inc"
Description="Mirum Pharmaceuticals, Inc., a biopharmaceutical company, is focused on the development and commercialization of an advanced line of novel therapies for debilitating liver diseases. The company is headquartered in Foster City, California."
CIK="1759425"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="950 TOWER LANE, SUITE 1050, FOSTER CITY, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1016237000"
EBITDA="-113494000"
PERatio="None"
PEGRatio="None"
BookValue="2.057"
DividendPerShare="0"
DividendYield="0"
EPS="-4.83"
RevenuePerShareTTM="3.136"
ProfitMargin="-1.523"
OperatingMarginTTM="-1.023"
ReturnOnAssetsTTM="-0.2"
ReturnOnEquityTTM="-1.863"
RevenueTTM="115781000"
GrossProfitTTM="64688000"
DilutedEPSTTM="-4.83"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.145"
AnalystTargetPrice="52"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="12.6"
PriceToBookRatio="3.955"
EVToRevenue="9.3"
EVToEBITDA="-16.18"
Beta="1.253"
num_52WeekHigh="30.39"
num_52WeekLow="17.32"
num_50DayMovingAverage="26.11"
num_200DayMovingAverage="23.87"
SharesOutstanding="38298000"
DividendDate="None"
ExDividendDate="None"
symbol="MIRM"
open="26.62"
high="26.85"
low="26.19"
price="26.35"
volume="151849.00"
latest_trading_day="2023-08-28"
previous_close="26.54"
change="-0.18"
change_percent="-0.6972%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="33"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="67"
Volume_recent_avg="585373"
Change_recent_avg="0.01"
Delta_recent_avg="1.07"
Variance_recent_avg="0.53"
Change_ratio_recent_avg="0.03"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="67"
Aroon_momentum_negative="33"
image_negative_thumbnail_id_1="490"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0115.jpeg"
image_negative_thumbnail_id_2="507"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_neutral_thumbnail_id_1="580"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0019.jpeg"
image_neutral_thumbnail_id_2="564"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0035.jpeg"
image_positive_thumbnail_id_1="637"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0071.jpeg"
image_positive_thumbnail_id_2="699"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
